-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Prelude Therapeutics Inc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2020 to Q1 2025.
- Prelude Therapeutics Inc Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$34.2M, a 7.68% decline year-over-year.
- Prelude Therapeutics Inc annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$103M, a 3.9% increase from 2023.
- Prelude Therapeutics Inc annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$107M, a 27.9% decline from 2022.
- Prelude Therapeutics Inc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$83.7M, a 0.24% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)